Takeda Pharmaceutical Company Limited Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2023-12-14: Form 6-K; Period of report 2023-12-14; Description FORM 6-K; Document form6k_121423.htm.
- 2023-11-30: Form 6-K; Period of report 2023-11-30; Description FORM 6-K; Document form6k_113023.htm.
- 2023-11-13: Form 6-K; Period of report 2023-11-13; Description FORM 6-K; Document form6k_111323.htm.
- 2023-10-30: Form 6-K; Period of report 2023-10-30; Description FORM 6-K; Document form6k_103023.htm.